Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
17hOpinion
Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
If you’ve been debating starting a weight-loss treatment like tirzepatide or semaglutide, you’re going to want to listen ...
Discover 5 expert-backed methods to target and reduce stubborn belly fat while improving your overall health. Implement these ...
Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 ...
Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...
Grammy award-winning singer Lizzo has shown off her transformed figure in new snaps that have left fans stunned.
There have been 274 hospitalisations associated with weight-loss injections - far higher than the 68 previously detailed by ...
An esteemed clinician has called on people to seek proper medical care when exploring weight-loss injections. Sara Cheeney, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback